Viking therapeutics inc.

Major-Pharmaceuticals

VKTX


12340 El Camino Real
San Diego , CA 92130

Executive/
Director

Price

  • Last Close
  • $ 47.91
    $ -2.42 -4.81 %
    Dec 10, 2024
  • 52-Week High/Low
  • $94.5 - $9.24
  • YTD
  • 157.4%

  • Trading Volume
  • 91,174
  • Market Cap Full
  • $ 4.8B
  • Shares Outstanding
  • 100M
    Oct 15, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -58.4% 22.7% 7.6% 29.9% -5% 9.2% -34.8% 77.1% 340.6%
Q2 -20.3% -11.3% -26% 119.2% -15.1% 4% -5.3% -3.7% -2.6% -2.7%
Q3 -17.9% 11.1% 76.9% 73.2% -19.5% 8% 4.8% -5.9% -31.7% -
Q4 -41.8% -15% 113.7% -52.8% 19.2% -0.5% -26.8% 245.6% 71.2% -
J F M A M J J A S O N D
2024 29.7% 219.2% 6.4% -5.7% - - - - - - - -
2023 -6.8% 25.7% 51.2% 28% 3.1% -26.2% -10.6% -4.8% -19.8% -11.4% 24.6% 52.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-65%241%88%5%-28%-21%104%98%157%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.40 0.23 -0.1 -0.07 -0.13 -0.19 -0.21 -0.25
Q2 1.07 0.22 0.21 -0.13 -0.11 -0.13 -0.2 -0.23 -0.19
Q3 0.53 0.20 0.22 -0.11 -0.08 -0.13 -0.17 -0.21 -0.23
Q4 0.56 0.18 0.14 -0.04 -0.1 -0.15 -0.15 -0.25 -
A 2.2 1 0.8 -0.4 -0.4 -0.5 -0.7 -0.9 -0.67

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 72 72.6 74.1 78.4 78.4
Jun 50.9 72 72.6 78.1 77.4 99.6
Sep 60.7 72.2 72.8 78.2 76.7 100
Dec 71.5 72.3 73 78.2 76.7 100

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 70 56 14.3 4.7 6.5
Equity multiplier - - - - -